Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

1,540 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 (+)-(s)-2-(6-methoxynaphthalen-2-yl) propanoic acid Propanoic acid 1件: D02310 💬 - - 1件: 271 💬
2 (2r)-2-propyloctanoic acid - - - - 1件:  2  💬
3 (2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-y1] butanamide - - - - 1件: 309 💬
4 (2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-yl] butanamide - - - - 1件: 309 💬
5 (6r)-4, 5, 6, 7 - tetrahydro-n6-propyl-2,6-benzothiazolidiamine dihydrochloride monohydrate - - - - 1件:  2  💬
6 (6s)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol - - - - 1件:  6  💬
7 (r)-(-)-2-propyloctaroic acid - - - - 1件:  2  💬
8 (r)-3-(1-oxo-propoxy)-4-(n,n,n-trimethyl amonium chloride)-butanoic acid Butyric Acid 1件: D05866 💬 - - 1件: 97 💬
9 (s)- 2- amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol - - - - 1件:  6  💬
10 (s)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium - - - - 1件: 86 💬
11 **comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter. - - - - 1件: 86 💬
12 0 mg prednisone Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 44 💬
13 0,5 mg prevenar i.m. - - - - 1件: 51 💬
14 10% nifedipine cream Nifedipine 1件: D00437 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 50 💬
15 10% nitroglycerine in propylene glycol, usp Nitroglycerin 2件: D00078, D00515 💬 - - 1件: 51 💬
16 17beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one - - - - 1件: 75 💬
17 17ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one - - - - 1件: 75 💬
18 1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- - - - - 1件:  6  💬
19 1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea - - - - 1件:  6  💬
20 1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- - - - - 1件:  6  💬
21 1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea - - - - 1件:  6  💬
22 2'-o-(2-methoxyethyl)-d-ribose antisense oligonucleotide targeting glial fibrillary acidic protein messenger ribonucleic acid Ribose - - - 1件: 131 💬
23 2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester - - - - 1件: 13 💬
24 3-(3-(3,5-dimethyl-1h-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid Pyrazole - - - 1件: 28 💬
25 5 mg prednisone Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 44 💬
26 5% lidocaine/5 mg/ml 0.02% estradiol compound cream Estradiol 11件: D00105, D00358, D01413, D01617, D01953, D02086, D04061, D04063, D04064, D04065, D08127 💬 7件: ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 12件: Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway 1件: 226 💬
27 5-aminosalicylic acid(5-asa) and/or prednisone Aminosalicylic acid 3件: D00162, D00377, D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
28 5-probe cocktail - - - - 1件: 254 💬
29 68ga-bnota-prgd2 - - - - 1件: 46 💬
30 90 mg hydrocortisone acetate suppository with sephure suppository applicator Acetate 2件: D00088, D00165 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
31 [rvt-1601 (in precedenza pa101b)] - - - - 1件: 85 💬
32 A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (cbus) - - - - 1件: 60 💬
33 A multistrain probiotic product (dsf) - - - - 1件: 97 💬
34 Abatacept prefilled syringe Abatacept 1件: D03203 💬 2件: CD80, CD86 💬 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 1件: 46 💬
35 Abp 959 - proposed biosimilar to eculizumab Eculizumab 1件: D03940 💬 1件: C5 💬 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 1件: 62 💬
36 Access program - sildenafil citrate, viagra, revatio Sildenafil 2件: D02229, D08514 💬 1件: PDE5A 💬 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 1件: 86 💬
37 Act-385781a (actelion epoprostenol) Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
38 Acthar injectable product - - - - 1件: 46 💬
39 Adalimumab prn Adalimumab 1件: D02597 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 96 💬
40 Adalimumab, plus prednisone Adalimumab 2件: D00473, D02597 💬 2件: NR3C1, TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
41 Adalimumab, solution for injection 40 mg/ (0.8 ml) pre-filled syringe Adalimumab 1件: D02597 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
42 Adeno-associated viral (aav) serotype 8 (aav2/8) vector with liver-specific thyroxine-binding globulin (tbg) promoter, driving the expression of the human arsb gene Levothyroxine 2件: D01010, D08125 💬 2件: THRA, THRB 💬 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 1件: 19 💬
43 Advagraf prolonged-release hard capsules - - - - 1件: 299 💬
44 Agua para preparaciones inyectables - - - - 1件: 78 💬
45 Aldesleukin Aldesleukin 1件: D00748 💬 3件: IL2RA, IL2RB, IL2RG 💬 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 4件: 49, 65, 96, 97 💬
46 Alirocumab Alirocumab 1件: D10335 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 1件: 79 💬
47 Alirocumab sar236553 (regn727) Alirocumab 1件: D10335 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 1件: 79 💬
48 Alkalinized lidocaine-heparin Heparin 4件: D00358, D02086, D07510, D08127 💬 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 1件: 226 💬
49 Allogeneic mesenchymal precursor cells - - - - 1件: 46 💬
50 Allogeneic neural retina-derived human neural retinal progenitor cells ex vivo expanded - - - - 1件: 90 💬
51 Alpha 1-proteinase inhibitor Alpha-1-proteinase inhibitor - - - 1件: 231 💬
52 Alpha 1-proteinase inhibitor (human) Alpha-1-proteinase inhibitor - - - 1件: 231 💬
53 Alpha-1 proteinase inhibitor (human) - - - - 1件: 231 💬
54 Alpha1-proteinase inhibitor Alpha-1-proteinase inhibitor - - - 2件: 231, 299 💬
55 Alpha1-proteinase inhibitor (human) Alpha-1-proteinase inhibitor - - - 2件: 231, 299 💬
56 Alprostadil Alprostadil 2件: D00180, D02705 💬 1件: PTGER1 💬 4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 2件: 51, 70 💬
57 Ambrisentan 5mg film-coated tablets [marketed product] Ambrisentan 1件: D07077 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
58 Amitriptyline, fluoxetine and tramadol alone (control group) Amitriptyline 6件: D00326, D00809, D00823, D01355, D07448, D08623 💬 3件: OPRM1, SLC6A2, SLC6A4 💬 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件: 78 💬
59 Amorphous calcium carbonate Calcium 2件: D00932, D10802 💬 - - 1件: 235 💬
60 Androgel 10 grams of gel containing 100 mg of testosterone Testosterone 6件: D00075, D00957, D00958, D00959, D06085, D06087 💬 1件: AR 💬 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer 1件: 13 💬
61 Antioxidant plus pregabalin Pregabalin 1件: D02716 💬 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 1件: 298 💬
62 Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
63 Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
64 Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
65 Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
66 Atenolol or propranolol Atenolol 3件: D00235, D00483, D08443 💬 3件: ADRB1, ADRB2, ADRB3 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 167 💬
67 Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv) Adenosine 1件: D00045 💬 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 65 💬
68 Autologous mesenchymal cell product - - - - 1件: 13 💬
69 Avatrombopag (proposed) Avatrombopag 1件: D10306 💬 - - 1件: 63 💬
70 Avxs-101 (previously known as scaav9.cb.smn) - - - - 1件:  3  💬
71 Azathioprine/prednisone Azathioprine 3件: D00238, D00473, D03033 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 85 💬
72 Azd4017 and prednisolone Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 75 💬
73 Bacteriophage preparation - - - - 1件: 96 💬
74 Bascial prescription plus or minus herbs depend on symptoms - - - - 1件: 97 💬
75 Befizal l.p. 400 mg, comprimé enrobé à libération prolongée - - - - 1件: 94 💬
76 Behavioral: 6 months weight resistance and balance program Isoxaflutole - - - 1件: 13 💬
77 Behavioral: administration of probiotic (l. rhamnosus and l. acidophilus) Lactobacillus acidophilus 1件: D04349 💬 - - 1件: 97 💬
78 Behavioral: co-op treatment protocol - - - - 1件:  6  💬
79 Behavioral: gait and balance training program Isoxaflutole - - - 1件:  6  💬
80 Behavioral: heart health educational program - - - - 1件: 49 💬
81 Behavioral: protein and calorie controlled diet - - - - 1件: 251 💬
82 Betamethasone Betamethasone 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 6件:  2 , 28, 46, 90, 96, 235 💬
83 Betamethasone acibutate Betamethasone 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
84 Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days Acetate 7件: D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件:  2  💬
85 Bi 695501 prefilled syringe - - - - 1件: 46 💬
86 Biib019 (daclizumab high yield process) Daclizumab 1件: D03639 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 1件: 13 💬
87 Biib041 (pr fampridine) Dalfampridine 1件: D04127 💬 4件: KCNA4, KCNC3, KCND2, KCND3 💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 1件: 13 💬
88 Bio-25 probiotic - - - - 1件: 299 💬
89 Biosimilar product to adalimumab Adalimumab 1件: D02597 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
90 Bladder instillation with heparin/ lidocaine Heparin 4件: D00358, D02086, D07510, D08127 💬 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 1件: 226 💬
91 Bladder instillation with triamcinolone acetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 226 💬
92 Bladder instillation without triamcinolone acetonide Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 226 💬
93 Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) Digoxin 13件: D00298, D00330, D00455, D00529, D00550, D00696, D01207, D01475, D02290, D05028, D05259, D05261, D08229 💬 25件: ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 49件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 46 💬
94 Bortezomib/dexamethasone Bortezomib 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 283 💬
95 Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone Bortezomib 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
96 Botox 100 unites allergan (pr1) - - - - 1件:  2  💬
97 Btt1023 iv infusion 20 mg/ml, 5 ml drug product - - - - 1件: 94 💬
98 Budesonide 6 mg capsules, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
99 Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
100 Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
101 Budesonide 9 mg capsules, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
102 Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
103 Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype) Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
104 Budesonide plus prevacid Budesonide 1件: D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
105 Bupivacaine/epinephrine/dexamethasone Bupivacaine 14件: D00095, D00292, D00975, D00996, D01450, D01510, D01615, D01632, D01948, D02149, D02174, D02591, D02592, D07552 💬 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 96 💬
106 Buprenorphine Buprenorphine 2件: D00836, D07132 💬 2件: OPRK1, OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 2件: 46, 70 💬
107 Buprenorphine transdermal patch Buprenorphine 2件: D00836, D07132 💬 2件: OPRK1, OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 46 💬
108 Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf Busulfan 8件: D00107, D00142, D00248, D01907, D02115, D03235, D07966, D08556 💬 9件: CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 46件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 60 💬
109 Bydureon 2 mg powder and solvent for prolonged-release suspension - - - - 1件:  6  💬
110 C326, il-6 inhibitory avimer protein - - - - 1件: 96 💬
111 Calcium carbonate Calcium 2件: D00932, D10802 💬 - - 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬
112 Calcium carbonate and alphacalcidol Calcium 2件: D00932, D10802 💬 - - 1件: 235 💬
113 Calcium carbonate d Calcium 2件: D00932, D10802 💬 - - 1件: 53 💬
114 Calcium lactate Calcium 2件: D00936, D02254 💬 - - 1件: 235 💬
115 Canakinumab (proposed) Canakinumab 1件: D09315 💬 1件: IL1B 💬 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 1件: 46 💬
116 Cardiovascular profile - - - - 1件: 113 💬
117 Caveolin-1-scaffolding-protein-derived peptide (lti-03) - - - - 1件: 85 💬
118 Cd34+ enriched, t cell depleted donor stem cell product - - - - 1件: 326 💬
119 Certolizumab pegol (cdp870, tradename cimzia)(prefilled syringes at the dose of 200mg) Certolizumab pegol 1件: D03441 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
120 Cgmp protein - - - - 1件: 97 💬
121 Chinese herb prescription granule plus prednisone Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
122 Cipro (ciprofloxacin, bayq3939) Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
123 Ciprofloxacin Ciprofloxacin 2件: D00186, D02216 💬 - - 5件:  2 , 60, 96, 97, 299 💬
124 Ciprofloxacin (bayq3939) dry powder for inhalation Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
125 Ciprofloxacin (cipro inhale, bayq3939) Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
126 Ciprofloxacin (cipro, bayq3939) Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
127 Ciprofloxacin (ciproxin) Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
128 Ciprofloxacin dispersion for inhalation Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
129 Ciprofloxacin dpi Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
130 Ciprofloxacin dpi (bayq3939) Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
131 Ciprofloxacin for inhalation Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
132 Ciprofloxacin hydrochloride Ciprofloxacin 2件: D00186, D02216 💬 - - 2件: 96, 299 💬
133 Ciprofloxacin hydrochloride monohydrate Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
134 Ciprofloxacin inhale Ciprofloxacin 2件: D00186, D02216 💬 - - 1件: 299 💬
135 Circadin 2 mg comprimidos de liberación prolongada - - - - 1件: 90 💬
136 Cis-4-hydroxy-l-proline Proline 1件: D00035 💬 - - 1件: 94 💬
137 Cisapride Cisapride 2件: D00274, D02092 💬 3件: HTR2A, HTR3A, HTR4 💬 7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 1件: 13 💬
138 Clartihromycin, amoxicillin, and omeprazole Amoxicillin 7件: D00229, D00455, D01207, D02925, D05259, D05261, D07452 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 1件:  6  💬
139 Clobetasol propionate Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 46, 162 💬
140 Clobetasol propionate + methotrexate Clobetasol 4件: D00142, D01272, D02115, D07715 💬 3件: DHFR, DHFR2, NR3C1 💬 6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 1件: 162 💬
141 Clobetasol propionate alone Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
142 Clobetasol propionate cream treatment Clobetasol 2件: D01272, D07715 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 162 💬
143 Coenzyme q10 and lisinopril Lisinopril 3件: D00362, D01065, D08131 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 1件: 113 💬
144 Colal pred - - - - 1件: 97 💬
145 Colal-pred - - - - 1件: 97 💬
146 Colal-pred® - - - - 1件: 97 💬
147 Colistimethate sodium (promixin) Colistimethate 1件: D02049 💬 - - 1件: 299 💬
148 Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine Azathioprine 12件: D00238, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994, D03033 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 35 💬
149 Combination oral budesonide and rectal hydrocortisone Budesonide 2件: D00088, D00246 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
150 Combination product (natpara) and drug or supplements [disease and drug registry] - - - - 1件: 235 💬
151 Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi) - - - - 1件: 86 💬
152 Combination product: active treatment with dual therapy - - - - 1件:  2  💬
153 Combination product: beclomethasone dipropionate in addition to mc-evoo Beclomethasone dipropionate 2件: D00689, D07495 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
154 Combination product: beclomethasone dipropionate in addition to refined oil Beclomethasone dipropionate 2件: D00689, D07495 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
155 Combination product: belimumab Belimumab 1件: D03068 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 1件: 49 💬
156 Combination product: goldic serum - - - - 1件: 70 💬
157 Combination product: hyperbaric oxygen therapy- Oxygen 1件: D00003 💬 - - 1件: 226 💬
158 Combination product: implantable system for remodulin (treprostinil) Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
159 Combination product: l-dopa 140 mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
160 Combination product: l-dopa 35 mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
161 Combination product: l-dopa 70mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
162 Combination product: l-dopa 70mg/carbidopa 7mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
163 Combination product: mavrilimumab Mavrilimumab 1件: D09930 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 1件: 41 💬
164 Combination product: methotrexate Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
165 Combination product: nd0612 solution for sc infusion - - - - 1件:  6  💬
166 Combination product: ofatumumab with ai Ofatumumab 1件: D09314 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 13 💬
167 Combination product: ofatumumab with prf Ofatumumab 1件: D09314 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 13 💬
168 Combination product: prp combined magnovision - - - - 1件: 90 💬
169 Combination product: transcon pth - - - - 1件: 235 💬
170 Combination product: treprostinil via implanted pump Treprostinil 1件: D06213 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
171 Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator Acetate 2件: D00088, D00165 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
172 Combination therapy with vigabatrin and prednisolone Prednisolone 9件: D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 2件: ABAT, NR3C1 💬 8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件: 145 💬
173 Continuation of current haart (boosted protease inhibitor [pi] combination + 2 nrtis) - - - - 1件: 265 💬
174 Control intervention (no dexamethasone) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
175 Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) Acetate 21件: D00088, D00292, D00472, D00473, D00973, D00975, D00980, D00981, D00982, D01239, D01510, D01615, D01632, D01948, D01998, D02156, D02174, D02591, D02592, D03301, D07749 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
176 Copaxone - 20 mg/ml soluzione iniettabile in siringhe preriempite 30 siringhe - - - - 1件: 13 💬
177 Copaxone - 40 mg/ml soluzione iniettabile in siringa preriempita 12 siringhe preriempite da 1 ml con ago - - - - 1件: 13 💬
178 Copaxone 20 mg/ml solución inyectable en jeringa precargada - - - - 1件: 13 💬
179 Copaxone 20 mg/ml solución para inyección en jeringa precargada - - - - 1件: 13 💬
180 Copaxone 20 mg/ml solution for injection, pre-filled syringe - - - - 1件: 13 💬
181 Copaxone 20 mg/ml, solution for injection, pre-filled syringes - - - - 1件: 13 💬
182 Copaxone 20mg/ml solution for injection, pre-filled syringe - - - - 1件: 13 💬
183 Copaxone 40 mg/ml solution for injection, pre-filled syringe - - - - 1件: 13 💬
184 Cortef (hydrocortisone) Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 83 💬
185 Corticosteroid (prednisolone) Prednisolone 8件: D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 85 💬
186 Corticosteroid treatment (methylprednisolone or prednisolone) Methylprednisolone 14件: D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 64 💬
187 Corticosteroids (prednisone or prednisolone) Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
188 Current marketed flolan (epoprostenol sodium) Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
189 Cyclo[l-alanyl-l-seryl-l-isoleucyl-l-prolyl-l-prolyl-l-glutaminyl-l-lysyl-l-tyrosyl-d-prolyl-l-prolyl-(2s)-2-aminodecanoyl-l-alpha-glutamyl-l-threonyl] - - - - 1件: 299 💬
190 Cyclophosphamide + pred Cyclophosphamide 2件: D00287, D07760 💬 - - 1件: 283 💬
191 Cyclophosphamide, azathioprine,prednisone,methylprednisolone Azathioprine 11件: D00238, D00287, D00407, D00473, D00751, D00979, D03033, D05000, D05001, D05002, D07760 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 42, 43, 45 💬
192 Cyclophosphamide, bortezomib, and dexamethasone (cybord) Bortezomib 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
193 Cyclophosphamide, bortezomib, dexamethasone Bortezomib 12件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬 2件: NR3C1, PSMB5 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 28 💬
194 Cyclophosphamide, bortezomib, dexamethasone plus daratumumab Bortezomib 13件: D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬 3件: CD38, NR3C1, PSMB5 💬 16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 1件: 28 💬
195 Cyclophosphamide-prednisone-azathioprine Azathioprine 5件: D00238, D00287, D00473, D03033, D07760 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 49 💬
196 Cyclosporin, methotrexate (gvhd prophylaxis) Cyclosporine 3件: D00142, D00184, D02115 💬 7件: DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 326 💬
197 Cyclosporine oral product Cyclosporine 1件: D00184 💬 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 1件: 60 💬
198 D-proline D-Proline 1件: D00035 💬 - - 1件: 97 💬
199 D.3.2 product code where applicable13: - - - - 1件: 193 💬
200 Dabigatran etexilate Dabigatran 2件: D07144, D09707 💬 1件: F2 💬 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 1件: 51 💬
201 Daclizumab high yield process Daclizumab 1件: D03639 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 1件: 13 💬
202 Decortin (prednisona) 5 mg comprimidos Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
203 Denosumab Denosumab 1件: D03684 💬 1件: TNFSF11 💬 7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 7件: 46, 50, 93, 95, 96, 274, 299 💬
204 Denosumab - - immunoglobulin g2 human monoclonal antibody to rank ligand Denosumab 1件: D03684 💬 1件: TNFSF11 💬 7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 1件: 274 💬
205 Denosumab - immunoglobulin g2 human monoclonal antibody to rank ligand Denosumab 1件: D03684 💬 1件: TNFSF11 💬 7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 1件: 274 💬
206 Device: abatacept combination product (acp) Abatacept 1件: D03203 💬 2件: CD80, CD86 💬 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 1件: 46 💬
207 Device: avonex prefilled syringe via manual im injection - - - - 1件: 13 💬
208 Device: biib017 (peginterferon beta-1a) pre-filled syringe (pfs) Peginterferon beta-1a 1件: D10483 💬 2件: IFNAR1, IFNAR2 💬 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 1件: 13 💬
209 Device: blood pressure - - - - 1件: 84 💬
210 Device: cell processing for tcrabeta+/cd19+ depletion - - - - 1件: 65 💬
211 Device: cell processing for tcraß+/cd19+ depletion - - - - 1件: 65 💬
212 Device: cic using lofric primo - - - - 1件: 13 💬
213 Device: dexamethasone injection Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 90 💬
214 Device: heparin-induced extracorporeal ldl precipitation Heparin 1件: D07510 💬 1件: SERPINC1 💬 1件: Complement and coagulation cascades 1件: 79 💬
215 Device: iowa oral pressure instrument - - - - 1件:  2  💬
216 Device: micro mouth pressure meter - - - - 1件:  2  💬
217 Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation Oxygen 1件: D00003 💬 - - 1件: 299 💬
218 Device: positive expiratory pressure - - - - 1件: 299 💬
219 Device: pre-filled syringe (pfs) - - - - 1件: 46 💬
220 Device: primus fgti (flexible great toe implant) Florasulam - - - 1件: 46 💬
221 Device: propofol dosage Propofol 1件: D00549 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件: 84 💬
222 Device: reciprocating procedure device (rpd) - avanca re no. 1091001 - - - - 1件: 46 💬
223 Device: single-use autoinjector with a prefilled liquid avonex syringe - - - - 1件: 13 💬
224 Device: the ozone generator device (human pro medic, german) Ozone - - - 1件: 51 💬
225 Dexamethasone Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
226 Dexamethasone (1 cycle) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 63 💬
227 Dexamethasone (4 cycles) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 63 💬
228 Dexamethasone (50mg 1dd6, 3 consecutive days/month) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 35 💬
229 Dexamethasone 0,1 mg tablets Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
230 Dexamethasone 0,5mg Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
231 Dexamethasone 0.5mg tablet Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
232 Dexamethasone 0.5mg/5ml solution Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 35, 162 💬
233 Dexamethasone 0.5mg/5ml solution in mucolox™ Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 35, 162 💬
234 Dexamethasone 1,5 mg tablets Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
235 Dexamethasone 21-dihydrogen phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
236 Dexamethasone 21-phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 97 💬
237 Dexamethasone 2mg tablets Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
238 Dexamethasone 4 mg jenapharm Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 28 💬
239 Dexamethasone abcur Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 63 💬
240 Dexamethasone and rituximab Dexamethasone 10件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994 💬 2件: MS4A1, NR3C1 💬 2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 1件: 63 💬
241 Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland). Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 235 💬
242 Dexamethasone parotid irrigation Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 53 💬
243 Dexamethasone sodium phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 3件: 65, 70, 96 💬
244 Dexamethasone sodium phosphate 250 mg/ 10 ml Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 96 💬
245 Dexamethasone sodium phosphate 250 mg/10 ml solution Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 299 💬
246 Dexamethasone sodium phosphate ph. eur. Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 65 💬
247 Dexamethasone sodium sulfate Dexamethasone 11件: D00292, D00975, D01510, D01615, D01632, D01732, D01948, D02174, D02591, D02592, D05877 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 28 💬
248 Dexamethasone soduim phosphate Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 13 💬
249 Dexamethasone, 40 mg Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 28 💬
250 Dexmedetomidine Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
251 Dexmedetomidine 1 Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件: 280 💬
252 Dexmedetomidine 2 Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件: 280 💬
253 Dexmedetomidine 3 Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件: 280 💬
254 Dexmedetomidine group Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件: 70 💬
255 Dexmedetomidine hydrochloride Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件: 70 💬
256 Dexmedetomidine hydrochloride infusion Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件:  6  💬
257 Dexmedetomidine with ropivacaine Dexmedetomidine 4件: D00514, D01205, D04048, D08490 💬 8件: ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 1件: 70 💬
258 Diagnostic test: beam test to predict falls Tricyclazole - - - 1件:  6  💬
259 Diagnostic test: biotherapy prescription with sinnotest® software - - - - 1件: 46 💬
260 Diagnostic test: dexamethasone test Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 75 💬
261 Diagnostic test: fecal microbiome probiotic - - - - 1件: 294 💬
262 Diagnostic test: preoparative blood laboratory tests - - - - 1件: 235 💬
263 Diagnostic test: pressure pain threshold - - - - 1件: 113 💬
264 Diagnostic test: pulmonary microbiome probiotic - - - - 1件: 294 💬
265 Diagnostic test: retrospective evaluation of endoscopy prior to study drug - - - - 1件: 98 💬
266 Diagnostic test: voc probiotic - - - - 1件: 294 💬
267 Diazoxide Diazoxide 1件: D00294 💬 2件: ABCC8, KCNJ11 💬 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 2件: 13, 193 💬
268 Diazoxide choline Choline 2件: D00294, D07690 💬 2件: ABCC8, KCNJ11 💬 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 1件: 193 💬
269 Diazoxide choline controlled-release tablet Choline 2件: D00294, D07690 💬 2件: ABCC8, KCNJ11 💬 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 1件: 193 💬
270 Diclofenac + omeprazole Diclofenac 7件: D00455, D00903, D00904, D01207, D05259, D05261, D07816 💬 4件: ATP4A, ATP4B, PTGS1, PTGS2 💬 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 46 💬
271 Dimebon + omeprazole Latrepirdine 5件: D00455, D01207, D05259, D05261, D09917 💬 8件: ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 26件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  8  💬
272 Dopamine agonists (pramipexole, ropirinole) Dopamine 4件: D00559, D00633, D05575, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
273 Dose of 60 mg/kg alpha1-proteinase inhibitor Alpha-1-proteinase inhibitor - - - 1件: 231 💬
274 Dose of 60 mg/kg fraction iv-1 alpha1-proteinase inhibitor Alpha-1-proteinase inhibitor - - - 1件: 231 💬
275 Doxepin Doxepin 2件: D00814, D07875 💬 3件: HRH1, SLC6A2, SLC6A4 💬 5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
276 Doxepin and zopiclone Doxepin 3件: D00814, D01372, D07875 💬 19件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬 10件: Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 1件:  6  💬
277 Dual release hydrocortisone (plenadren) Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
278 Dupilumab prefilled syringe Dupilumab 1件: D10354 💬 1件: IL4R 💬 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 1件: 160 💬
279 Egg white protein Egg - - - 1件: 96 💬
280 Egg yolk preparation with cholesterol Cholesterol 1件: D00040 💬 - - 1件: 310 💬
281 Eltrombopag Eltrombopag 1件: D03978 💬 - - 5件: 60, 63, 65, 284, 285 💬
282 Eltrombopag (revolade) Eltrombopag 1件: D03978 💬 - - 1件: 63 💬
283 Eltrombopag 12.5 mg Eltrombopag 1件: D03978 💬 - - 1件: 60 💬
284 Eltrombopag 25 mg Eltrombopag 1件: D03978 💬 - - 1件: 60 💬
285 Eltrombopag combining rituximab Eltrombopag 2件: D02994, D03978 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 63 💬
286 Eltrombopag olamine Eltrombopag 1件: D03978 💬 - - 2件: 60, 63 💬
287 Eltrombopag olamine (sb-497115-gr) Eltrombopag 1件: D03978 💬 - - 1件: 63 💬
288 Eltrombopag olamine, revolade, promacta Eltrombopag 1件: D03978 💬 - - 1件: 63 💬
289 Eltrombopag oral tablets Eltrombopag 1件: D03978 💬 - - 1件: 63 💬
290 Enbrel - 50 mg soluzione iniettabile in siringa (vetro da 1 ml) preriempita - uso sottocutaneo 12 siringhe preriempite + 24 tamponi imbevuti di alcol - - - - 1件: 46 💬
291 Enbrel 50 mg solution for injection in pre-filled syringe - - - - 1件: 46 💬
292 Enbrel 50mg pre-filled pen - - - - 1件: 46 💬
293 Enbrel 50mg pre-filled syringe - - - - 1件: 46 💬
294 Enbrel pre-filled pen - - - - 1件: 46 💬
295 Enbrel pre-filled syringe - - - - 1件: 46 💬
296 Enbrel® 50 mg solution for injection in pre-filled syringe - - - - 1件: 46 💬
297 Engineerd protein inhibitor of human neutrophil elastase - - - - 1件: 299 💬
298 Engineered protein inhibitor of human neutrophil elastase - - - - 1件: 299 💬
299 Ensure high protein - - - - 1件: 299 💬
300 Epinephrine Epinephrine 3件: D00095, D00996, D02149 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件: 46, 96 💬
301 Epoprostenol Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
302 Epoprostenol for injection Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
303 Epoprostenol sodico Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
304 Epoprostenol sodium Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
305 Epoprostenol-actelion Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
306 Erythromycin Erythromycin 9件: D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054 💬 - - 5件:  6 , 36, 164, 228, 291 💬
307 Erythropoietin Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 9件:  2 ,  6 , 13, 18, 22, 47, 70, 95, 96 💬
308 Erythropoietin human recombinant (eporh) Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件:  6  💬
309 Etanercept pre-filled syringe Etanercept 1件: D00742 💬 2件: LTA, TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
310 Etanercept pre-filled syringe sq injection Etanercept 1件: D00742 💬 2件: LTA, TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
311 Etanercept, methotrexate, prednisolone Etanercept 11件: D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬 5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 56 💬
312 Eus procedure with drug injection - - - - 1件: 298 💬
313 Evaluation of biological predictive factors of clinical response to ustekinumab Ustekinumab 1件: D09214 💬 3件: IL12A, IL12B, IL23A 💬 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 1件: 96 💬
314 Everolimus oral product Everolimus 1件: D02714 💬 1件: MTOR 💬 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 2件: 89, 158 💬
315 Exelon patch (rivastigmine transdermal system) Rivastigmine 2件: D02558, D03822 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
316 Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14) - - - - 1件: 13 💬
317 Fampyra 10 mg prolonged-release tablets - - - - 1件: 13 💬
318 Fampyra 10mg prolonged release tablets - - - - 1件: 13 💬
319 Fentanyl (low dose) + dexmedetomidine Dexmedetomidine 4件: D00320, D00514, D01205, D01399 💬 4件: ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件: 215 💬
320 Finasteride Finasteride 1件: D00321 💬 1件: SRD5A2 💬 2件: Prostate cancer, Steroid hormone biosynthesis 1件:  6  💬
321 Fixed dose combination ciprofloxacin/celecoxib Celecoxib 3件: D00186, D00567, D02216 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件:  2  💬
322 Fluconazole Fluconazole 2件: D00322, D01429 💬 - - 2件: 96, 225 💬
323 Fluoxetine Fluoxetine 2件: D00326, D00823 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 4件: 13, 17, 78, 86 💬
324 Fluoxetine hydrochloride Fluoxetine 2件: D00326, D00823 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件: 13 💬
325 Fluticasone propionate Fluticasone 2件: D01708, D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 2件: 98, 228 💬
326 Fluticasone propionate, 800 mcg twice daily (post 4fed failure) Fluticasone 2件: D01708, D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
327 Fluticasone propionate, 880 mcg twice daily (after 6fed failure) Fluticasone 2件: D01708, D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
328 Fluticasone propionate, usp Fluticasone 2件: D01708, D07981 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 98 💬
329 Freshly-pressed extra virgin olive oil Olea europaea leaf 1件: D03311 💬 - - 1件: 13 💬
330 G2-sfm (ifn-beta-1a from clone 484-39,fbs-free process) - - - - 1件: 13 💬
331 Gabapentin prescriptions Gabapentin 1件: D00332 💬 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 1件: 298 💬
332 Gadoteridol Gadoteridol 1件: D01137 💬 - - 1件: 13 💬
333 Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado - - - - 1件: 13 💬
334 Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one) Ganaxolone 1件: D04300 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件: 152 💬
335 Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one) Ganaxolone 1件: D04300 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件: 152 💬
336 Genetic: protein expression analysis - - - - 2件: 28, 60 💬
337 Genetically engineered hematopoietic stem progenitor cells - - - - 1件: 285 💬
338 Genetically engineered hematopoietic stem/progenitor cells - - - - 1件: 285 💬
339 Glucocorticoid (prednisone or prednisolone) Prednisolone 9件: D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 84 💬
340 Glycomacropeptide-based protein substitute - - - - 1件: 240 💬
341 Golimumab final vialed product (fvp) Golimumab 1件: D04358 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
342 Golimumab liquid in prefilled pen Golimumab 1件: D04358 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
343 Golimumab liquid in prefilled pen or prefilled syringe Golimumab 1件: D04358 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
344 Golimumab liquid in prefilled syringe Golimumab 1件: D04358 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 3件: 46, 84, 97 💬
345 Golimumab pre-filled syringe Golimumab 1件: D04358 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 2件: 46, 271 💬
346 Golimumab prefilled pen Golimumab 1件: D04358 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
347 Golimumab prefilled pen or prefilled syringe Golimumab 1件: D04358 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
348 Golimumab prefilled syringe Golimumab 1件: D04358 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 97 💬
349 Gp2013 - a proposed biosimilar rituximab Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 46 💬
350 Granulocyte-colony stimulating factor (g-csf) and prednisone Filgrastim 2件: D00473, D03235 💬 2件: CSF3R, NR3C1 💬 6件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 1件: 13 💬
351 Group a sle prospective study - - - - 1件: 49 💬
352 Gsk1605786 gsk modified-process: formulation d - - - - 1件: 96 💬
353 Gvhd prophylaxis - - - - 2件: 60, 65 💬
354 Heparin & alkalinized lidocaine bladder instillation Heparin 4件: D00358, D02086, D07510, D08127 💬 6件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SERPINC1 💬 4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 1件: 226 💬
355 Hepatitis b virus surface antigen recombinant (s protein) - - - - 1件: 46 💬
356 Heterologous human adult liver-derived progenitor cells - - - - 1件: 251 💬
357 Heterologous human adult liver-derived progenitor cells (hhalpc) - - - - 1件: 251 💬
358 High dose dexamethasone pulses Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 63 💬
359 High protein high fiber diet - - - - 2件: 93, 95 💬
360 High protein. t-diet plus range - - - - 1件:  6  💬
361 Hormonal profile - - - - 1件: 113 💬
362 Hormone (prednisone) Prednisone 1件: D00473 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 66 💬
363 Hpv prophylactic vaccine gardasil - - - - 1件: 49 💬
364 Human anti-promyostatin monoclonal antibody - - - - 1件:  3  💬
365 Human glucocerebrosidase (prgcd) Taliglucerase alfa 1件: D09675 💬 1件: GBA 💬 4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 1件: 19 💬
366 Human monoclonal antibody directed against complement 5 protein - - - - 1件: 62 💬
367 Human primary retinal pigment epithelial (hurpe) cells - - - - 1件: 90 💬
368 Human recombinant tissue non-specific alkaline phosphatase fusion protein Alkaline Phosphatase - - - 1件: 172 💬
369 Human retinal progenitor cells - - - - 1件: 90 💬
370 Human retinal progenitor cells drug product - - - - 1件: 90 💬
371 Humira 20 mg solution for injection in pre-filled syringe - - - - 1件: 96 💬
372 Humira 40 mg injekcní roztok v predplnené injekcní stríkacce - - - - 1件: 96 💬
373 Humira 40 mg solución inyectable en jeringa precargada - - - - 2件: 46, 96 💬
374 Humira 40 mg solution for injection in pre-filled pen - - - - 1件: 96 💬
375 Humira 40 mg solution for injection in pre-filled syringe - - - - 3件: 46, 96, 97 💬
376 Humira 40 mg solution for injection in pre-filled syringes - - - - 1件: 97 💬
377 Humira 40mg solution for injection in pre-filled syringe - - - - 1件: 46 💬
378 Humira 40mg solution for injection in pre-filled syringe (adalimumab) Adalimumab 1件: D02597 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
379 Humira 40mg/0.4ml pre-filled syringe - - - - 1件: 96 💬
380 Humira 40mg/0.8ml solution for injection in pre-filled syringe - - - - 1件: 46 💬
381 Humira pre-filled pen - - - - 1件: 96 💬
382 Humira ® (adalimumab) 40mg/0.8ml pre-filled syringe Adalimumab 1件: D02597 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
383 Humira, 40 mg solution for injection in pre-filled syringe - - - - 1件: 46 💬
384 Humira® 40 mg solution for injection in pre-filled syringe - - - - 1件: 46 💬
385 Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe - - - - 1件: 46 💬
386 Hydrocortisone Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 9件:  6 , 46, 53, 75, 78, 81, 83, 97, 299 💬
387 Hydrocortisone (solucortef) Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
388 Hydrocortisone 100mg/ml Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 83 💬
389 Hydrocortisone 10mg Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
390 Hydrocortisone 10mg tablet Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
391 Hydrocortisone 10mg tablets Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
392 Hydrocortisone 20mg tablets Hydrocortisone 1件: D00088 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 81 💬
393 Hydrocortisone acetate Acetate 2件: D00088, D00165 💬